Figure 3.

Effect of itraconazole, 17‐OH itraconazole, or GS‐441524 on SARS‐CoV‐2 vRNA yield and viability in VeroE6‐eGFP cells (A) and (B) Mean differences in vRNA in the supernatant between untreated cultures and treated cultures at 48 h postinfection with SARS‐CoV‐2‐Belgium of one independent experiment containing two replicates (A) or three replicates (B) is shown. Error bars represent the standard deviation. (C, D) Mean viability of the cells, based on MTT readout of uninfected cells. Error bars represent the standard deviation. SARS‐CoV‐2, severe acute respiratory syndrome coronavirus 2; vRNA, viral RNA